For years, healthcare practice owners preparing for a sale, merger, or strategic partnership focused primarily on a familiar group of questions:

Those questions still matter.

But another question is becoming increasingly important:

Can your practice—and the proposed transaction—actually withstand the financial, operational, legal, and regulatory scrutiny that comes with sophisticated buyer due diligence?

Recent developments in California illustrate why this question deserves the attention of healthcare practice owners across the country.

California Is Increasing Scrutiny of Healthcare Transactions

In September 2026, California's Office of Health Care Affordability moved forward with regulations designed to expand reporting requirements surrounding certain healthcare transactions involving private equity firms and Management Services Organizations, commonly known as MSOs.

The regulations address transactions in which private equity or hedge-fund investors obtain certain financial interests, governance rights, or operational influence involving healthcare organizations and MSOs.

California already requires advance notification for certain covered healthcare transactions, and regulatory review can potentially add time and complexity to the closing process.

While these particular regulations apply to California, practice owners elsewhere should pay attention.

A growing number of states are examining healthcare ownership, private-equity investment, MSO structures, physician independence, corporate practice of medicine requirements, and healthcare transaction reporting.

Two Practices Can Have the Same EBITDA—and Very Different Value to a Buyer

Imagine two healthcare practices.

Both generate similar revenue. Both produce approximately the same EBITDA. Both have interested buyers.

But there is an important difference.

Practice A has clean financial statements, documented operating procedures, appropriate clinical oversight, organized employment agreements, clearly defined ownership structures, properly documented physician relationships, and contracts that can be readily reviewed.

Practice B has informal arrangements, inconsistent financial reporting, undocumented physician or medical-director relationships, outdated agreements, heavy dependence upon the owner, and ownership or compensation structures that haven't been reviewed in years.

From the owners' perspective, the practices may appear financially similar.

From a sophisticated buyer's perspective, however, they can represent very different levels of risk.

And risk can affect:

• Valuation
• Deal structure
• Financing
• Representations and warranties
• Escrow requirements
• Earnouts
• Closing timelines
• Whether the transaction closes at all

Why This Is Particularly Important for Medical Spa Owners

Medical spas occupy a unique position at the intersection of healthcare, aesthetics, wellness, and consumer services.

A successful medical spa may generate significant cash-pay revenue from services such as injectables, lasers, body treatments, skin rejuvenation, medical-grade skincare, weight-management programs, and other elective services.

That can make medical aesthetics attractive to strategic buyers and private-equity-backed platforms.

But because many of these services constitute medical care, medical spas can also be subject to regulations governing:

• Ownership of medical practices
• Corporate practice of medicine
• Physician and medical-director relationships
• Provider scope of practice
• Clinical supervision
• Management Services Organizations
• Management fees and compensation arrangements
• Provider licensing and credentialing
• Prescribing and telehealth
• Patient records and HIPAA
• Informed consent
• Advertising claims

Requirements can vary substantially from one state to another.

A rapidly growing medical spa may therefore have excellent revenue and EBITDA while simultaneously accumulating regulatory or operational risks that haven't received enough attention.

Those problems may remain hidden for years.

Then a sophisticated buyer begins due diligence.

That's a terrible time for the owner to discover them.

Podiatry Practices Face Their Own Due Diligence Challenges

For podiatrists, regulatory and operational diligence is particularly important because buyers are acquiring or partnering with physician practices.

A buyer may evaluate far more than historical revenue and profitability.

Physician Employment Agreements

Are key providers contractually positioned to remain following a transaction?

Provider Productivity

How much revenue is generated by each physician or provider?

Payer Mix

How dependent is the practice on particular insurers or reimbursement sources?

Billing and Coding

Are revenue-cycle processes accurate and defensible?

Referral Concentration

Does too much revenue depend upon a small number of referral sources?

Compliance

Are appropriate policies, documentation, and oversight in place?

Owner Dependence

What happens to revenue when the selling physician eventually leaves?

Management Depth

Can the practice function effectively without the current owner controlling day-to-day operations?

Wellness Businesses Are Entering the Same Conversation

The traditional lines separating healthcare, medical aesthetics, and wellness are rapidly disappearing.

From an M&A perspective, this convergence can create interesting opportunities.

A medical-aesthetics platform may find a women's-health or hormone practice strategically attractive. A wellness platform might add medical aesthetics. A medical spa may introduce weight-management or longevity programs.

Established healthcare platforms may view these services as opportunities to generate additional recurring or cash-pay revenue from an existing patient population.

But this convergence also introduces regulatory complexity.

A wellness business that originally operated primarily as a consumer service may gradually add medical services, prescription medications, telehealth, and licensed healthcare professionals.

Revenue may grow much faster than the organization's compliance infrastructure.

Private Equity Hasn't Stopped Buying—But Buyers Are Becoming More Selective

This increased regulatory scrutiny is occurring alongside another important development in healthcare M&A.

Private equity and PE-backed healthcare platforms continue to pursue acquisitions.

In particular, smaller add-on or tuck-in acquisitions can remain attractive because they allow established platforms to expand geographically, add providers, increase EBITDA, enter new markets, and introduce complementary services without completing another massive platform acquisition.

That's potentially good news for independent healthcare practice owners.

Your business doesn't necessarily need to generate tens of millions of dollars in revenue to become strategically interesting.

A smaller practice may provide something an established platform wants:

• A desirable geographic market
• Talented providers
• A strong local reputation
• An attractive patient population
• Recurring revenue
• Complementary services
• A foothold in a market where the buyer wants to expand

Your strategic value to a particular buyer may be greater than your size suggests.

But there's an important catch.

Today's buyers increasingly want businesses they can actually integrate.

Being Profitable Is Not the Same as Being Transaction-Ready

Historically, some owners considered themselves prepared for a sale if they had several years of tax returns and could demonstrate healthy profits.

That is no longer enough.

Financial Readiness

Are your financial statements clean and reliable? Can you clearly demonstrate normalized EBITDA? Can adjustments and add-backs withstand buyer scrutiny?

Operational Readiness

Are your processes documented? Is there management depth beyond the owner? Could the business continue operating successfully if you were no longer there every day?

Customer and Revenue Readiness

How concentrated is your revenue? How strong is patient retention? How much recurring or repeat revenue does the business generate?

Legal and Compliance Readiness

Are licenses, contracts, provider arrangements, policies, and compliance documentation organized and current?

Human Resources Readiness

Are key employees and providers likely to remain after a transaction? Are compensation plans and employment agreements documented?

Technology and Cybersecurity Readiness

Are your systems reliable? Can a buyer obtain accurate operational and financial data? Are patient and business information adequately protected?

Growth and Strategic Readiness

Can you clearly demonstrate where future growth will come from? Is growth dependent entirely upon the current owner—or is there a repeatable strategy?

Transaction Readiness

Are your corporate, ownership, management, and clinical structures capable of surviving sophisticated buyer due diligence?

Don't Wait Until You Receive an LOI

One of the biggest mistakes a practice owner can make is waiting until an interested buyer presents a Letter of Intent before preparing for due diligence.

At that point, the clock is already running.

And the buyer controls much of the process.

Problems discovered during due diligence can result in delays, additional representations and warranties, larger escrows, earnouts, changes in transaction structure, purchase-price reductions—or the buyer walking away entirely.

Some problems can be corrected relatively quickly.

Others may require six months, a year, or even several years to properly address.

That's why owners considering a sale, merger, or strategic partnership within the next one to three years should consider evaluating their transaction readiness now.

What Buyers Are Really Purchasing

A sophisticated buyer isn't simply purchasing your historical revenue.

And they're not simply purchasing last year's EBITDA.

They're purchasing the expectation that the business will continue producing cash flow after the transaction closes and eventually after you leave.

That means buyers increasingly want answers to questions such as:

• Can the revenue be transferred?
• Will the patients remain?
• Will key providers stay?
• Can the business operate without the owner?
• Are the financial statements reliable?
• Are the clinical arrangements compliant?
• Can the business be integrated into a larger organization?
• Are there hidden liabilities?
• Can the transaction be structured under applicable state regulations?

The fewer unanswered questions a buyer encounters, the easier it becomes to evaluate an acquisition with confidence.

And buyer confidence matters.

The Bottom Line for Healthcare Practice Owners

Healthcare consolidation isn't disappearing.

Private equity, strategic buyers, and PE-backed platforms continue to pursue opportunities in medical aesthetics, podiatry, physician practices, and selected wellness businesses.

But the market is becoming more sophisticated.

Financial performance matters. Growth matters. EBITDA matters.

But so do compliance, management depth, documentation, revenue quality, operational systems, provider retention, and transaction structure.

Owners considering a future sale, merger, recapitalization, or strategic partnership should evaluate their practice through the same lens a sophisticated buyer eventually will— before that buyer begins due diligence.